Inventor · Newbury Park, CA, US

Colin Gegg

36Patents
16h-index
44Co-inventors
81Inventor score

Filing activity: Aug 15, 1997 → Dec 3, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US6586398B1 Chemically modified novel erythropoietin stimulating protein compositions and methods Human Necessities 170 Expired
US6420339B1 Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility Human Necessities 160 Expired
US7442778B2 Modified Fc molecules Chemistry; Metallurgy 111 Expired
US8907071B2 Toxin peptide therapeutic agents Chemistry; Metallurgy 57 Active
US7662931B2 Modified Fc molecules Chemistry; Metallurgy 52 Active
US8008453B2 Modified Fc molecules Chemistry; Metallurgy 47 Active
US7750128B2 Modified Fc molecules Chemistry; Metallurgy 46 Active
US7833979B2 Toxin peptide therapeutic agents Chemistry; Metallurgy 36 Active
US7655765B2 Modified Fc molecules Chemistry; Metallurgy 35 Active
US7655764B2 Modified Fc molecules Chemistry; Metallurgy 35 Active
US7750127B2 Modified Fc molecules Chemistry; Metallurgy 33 Active
US7645861B2 Modified Fc molecules Chemistry; Metallurgy 33 Active
US9102731B2 Human CGRP receptor binding proteins Physics 22 Active
US5900404A Chemical modification of proteins to improve biocompatibility and bioactivity Human Necessities 21 Expired
US8420779B2 Compositions and methods for producing bioactive fusion proteins Chemistry; Metallurgy 17 Active
US8168592B2 CGRP peptide antagonists and conjugates Chemistry; Metallurgy 16 Active
US8541201B2 Thrombopoietic compounds Chemistry; Metallurgy 9 Active
US6017876A Chemical modification of granulocyte-colony stimulating factor (G-CSF) bioactivity Human Necessities 9 Expired
US7834164B2 DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expression Chemistry; Metallurgy 9 Active
US7820623B2 Conjugated toxin peptide therapeutic agents Chemistry; Metallurgy 7 Active
US9862771B2 Human CGRP receptor binding proteins Physics 7 Active
US6204247A Chemical modification of proteins to improve biocompatibility and bioactivity Human Necessities 6 Expired
US7262166B2 Chemically modified novel erythropoietin stimulating protein compositions and methods Human Necessities 4 Expired
US8043829B2 DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression Chemistry; Metallurgy 4 Active
US7910102B2 Methods of using conjugated toxin peptide therapeutic agents Chemistry; Metallurgy 3 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.